Novo Nordisk A/S (NVO)
NYSE: NVO · Real-Time Price · USD
50.88
-0.34 (-0.66%)
At close: Dec 31, 2025, 4:00 PM EST
50.77
-0.11 (-0.22%)
After-hours: Dec 31, 2025, 7:59 PM EST
Novo Nordisk (NVO) Operating Income by Segment
History
| Date | Diabetes and Obesity Care | Rare Disease |
|---|---|---|
| Jun 30, 2025 | 22.10B | 330.50M |
| Mar 31, 2025 | 21.17B | 84.19M |
| Dec 31, 2024 | 20.06B | 97.39M |
| Sep 30, 2024 | 18.49B | 103.83M |
| Jun 30, 2024 | 17.43B | 79.17M |
| Mar 31, 2024 | 16.76B | 429.61M |
| Dec 31, 2023 | 15.65B | 463.54M |
| Sep 30, 2023 | 14.23B | 364.27M |
| Jun 30, 2023 | 12.88B | 652.35M |
| Mar 31, 2023 | 11.81B | 862.37M |
| Dec 31, 2022 | 10.59B | 1.16B |
| Sep 30, 2022 | 9.78B | 1.43B |
| Jun 30, 2022 | 8.98B | 1.45B |
| Mar 31, 2022 | 8.40B | 1.47B |
| Dec 31, 2021 | 7.78B | 1.43B |
| Sep 30, 2021 | 7.35B | 1.48B |
| Jun 30, 2021 | 6.83B | 1.61B |
| Mar 31, 2021 | 6.72B | 1.58B |
| Dec 31, 2020 | 6.87B | 1.63B |
| Sep 30, 2020 | 6.86B | 1.75B |
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.